We are live on
!
Find out more
HC
Hendley & Co Portfolio holdings
AUM
$283M
1-Year Est. Return
19.89%
This Fund
S&P 500
This Quarter
Est. Return
-1.85%
1 Year Est. Return
+19.89%
3 Year Est. Return
+54.78%
5 Year Est. Return
+79.2%
10 Year Est. Return
+322.34%
AUM
$286M
AUM Growth
-$12.7M
(-4.2%)
Cap. Flow
-$5.61M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
44.8%
Holding
73
New
4
Increased
22
Reduced
27
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pentair
PNR
|
+$4.51M |
| 2 |
Lam Research
LRCX
|
+$2.88M |
| 3 |
Air Products & Chemicals
APD
|
+$1.55M |
| 4 |
HOLX
Hologic
HOLX
|
+$1.26M |
| 5 |
Union Pacific
UNP
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T. Rowe Price
TROW
|
+$7.27M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$5.79M |
| 3 |
JPMorgan Chase
JPM
|
+$4.87M |
| 4 |
Kimberly-Clark
KMB
|
+$2.7M |
| 5 |
Home Depot
HD
|
+$82.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Consumer Staples | 16.82% |
| 3 | Financials | 16.02% |
| 4 | Healthcare | 12.36% |
| 5 | Industrials | 10.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
UnitedHealth
UNH
$376B
| $638K | 0.22% |
1,633
| – | – |
|
52
Unilever
UL
$137B
| $598K | 0.21% |
9,809
-133
| -1% | -$8.47K |
|
53
Medtronic
MDT
$109B
| $565K | 0.2% |
+4,508
| New | +$583K |
|
54
TJX Companies
TJX
$174B
| $549K | 0.19% |
8,320
| – | – |
|
55
Lockheed Martin
LMT
$134B
| $512K | 0.18% |
1,483
| – | – |
|
56
Cummins
CMI
$87.5B
| $473K | 0.17% |
2,105
+105
| +5% | +$24.6K |
|
57
Mastercard
MA
$502B
| $461K | 0.16% |
1,325
| – | – |
|
58
Intel
INTC
$455B
| $460K | 0.16% |
8,629
+250
| +3% | +$13.6K |
|
59
Berkshire Hathaway Class A
BRK.A
$1.1T
| $411K | 0.14% |
1
| – | – |
|
60
Norfolk Southern
NSC
$75.4B
| $389K | 0.14% |
1,625
| – | – |
|
61
Colgate-Palmolive
CL
$73.1B
| $376K | 0.13% |
4,976
-134
| -3% | -$10.6K |
|
62
Nike
NKE
$61.9B
| $366K | 0.13% |
2,520
-75
| -3% | -$12.2K |
|
63
Amgen
AMGN
$208B
| $347K | 0.12% |
1,631
| – | – |
|
64
Texas Instruments
TXN
$252B
| $346K | 0.12% |
1,800
| – | – |
|
65
Gilead Sciences
GILD
$162B
| $322K | 0.11% |
4,617
| – | – |
|
66
AstraZeneca
AZN
$263B
| $300K | 0.1% |
2,500
| – | – |
|
67
Hormel Foods
HRL
$13.8B
| $267K | 0.09% |
6,500
| – | – |
|
68
NVIDIA
NVDA
$4.86T
| $264K | 0.09% |
12,760
| – | – |
|
69
ConocoPhillips
COP
$147B
| $250K | 0.09% |
3,694
+100
| +3% | +$5.77K |
|
70
UGI
UGI
$7.74B
| $219K | 0.08% |
+5,140
| New | +$235K |
|
71
Deere & Co
DE
$160B
| $201K | 0.07% |
600
| – | – |
|
|
72
Kimberly-Clark
KMB
$36.3B
| – | – |
-20,185
| Closed | -$2.7M |
|
Similar funds
DRD
TC
UFAC
WE
DIP
3CP
BO
MFG
Hendley & Co's Q3 2021 Portfolio in Review
As of Q3 2021, Hendley & Co held 73 positions worth $286M, down 4.2% from $299M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Hendley & Co's Q3 2021 filing shows 4 new, 22 increased, 27 reduced and 1 closed positions. Its largest new stake was Lam Research: 47,420 shares worth $2.7M. The largest sale was T. Rowe Price, an estimated $7.27M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Consumer Staples and Financials.
- Hendley & Co's largest Q3 2021 buy was Lam Research: 47,420 shares worth $2.7M.
- Hendley & Co added most to Pentair in Q3 2021, an estimated $4.51M increase.
- Hendley & Co's biggest Q3 2021 reduction was T. Rowe Price, cutting an estimated $7.27M.
- Hendley & Co fully exited Kimberly-Clark in Q3 2021, selling an estimated $2.7M.
- Hendley & Co's ten largest holdings make up 45% of its $286M portfolio in Q3 2021.
- Hendley & Co opened 4 new positions and closed 1 in Q3 2021.
- Hendley & Co's portfolio value fell 4.2% quarter-over-quarter to $286M.
Based on Hendley & Co's 13F filing for Q3 2021, filed 27 Oct 2021.